I am Chief Investigator for several CLL and lymphoma trials, all funded/endorsed by CR-UK, as well as a large observational study. Research themes are patient stratification and optimising the balance between treatment efficacy and toxicity.
I established a national biobank for CLL which has been extended to include lymphoma. Funded by Blood Cancer UK (www.bloodcancer.org.uk) with £3.5M investment from GEL for CLL whole genome sequencing as a pilot for the 100K Genomes Project. Showcased at the 2013 NCRI Cancer Conference and used as an NCRI impact case study
I have contributed to numerous clinical and laboratory research studies via active engagement with local, national and international collaborative networks.